Skip to content
ES
MARKETS / JRSS
SERVICES-HOSPITALS · SMALL CAP

Jrsis Health Care Corp. JRSS

11 fiscal years on record · USD · FY2023 reported · SEC filings only
$3.5M
▲ 101.4% YoY
$-80,912
$515,240
In brief

What this company does

JRSIS Health Care Corporation owns 100% of the equity in Laidian Technology (Zhongshan) Co., Ltd. through two wholly owned subsidiaries: JRSIS Health Care Limited and Runteng Medical Group Company Limited. Due in part to limitations under PRC law on foreign investment in value-added telecommunications services, we conduct substantially all of the operations in China reflected in our financial statements through contractual arrangements with Yongzhou Jumi, our consolidated variable interest entity (“VIE”), and its shareholders. We do not hold any equity interest in Yongzhou Jumi. We depend on Yongzhou Jumi to operate substantially all of the business reflected in our financial statements.

Written from the business description in JRSIS Health Care Corporation's annual report to the U.S. Securities and Exchange Commission, filed 26 April 2024. Every sentence was checked against that document before publication.

Growth
USD 3.5M
Revenue, FY2023 · full 11-year series below
Revenue $M Net income $M
FY2023 · Revenue 3.5 · Net income -0.1
20M40M201320152017201920212023
Compound annual growth
−54.1%
−34.4%
−2.3%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −34.4% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−3 cents
lost on every revenue dollar
Operating margin Net margin
FY2023 · Operating -5.4% · Net -2.7%
10%20%30%-10%-20%-30%201320152017201920212023
ROE
FY2022 · ROE -5.2%
50%201320152017201920212023
Gross margin14.0%
Operating margin-5.4%
Net margin-2.7%
Return on assets-4.5%
EBITDAUSD -172,088.00

Cash & shareholders
—
returned in FY2023 · dividends + net buybacks
Free cash flow $M
FY2023 · FCF 0.5
2.5M5.0M-1.0M-2.0M201320152017201920212023
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—

Total assetsUSD 2.1M
EquityUSD -137,406.00
CashUSD 118,114.00
Gross debtUSD 43,663.00
Net debtUSD -74,451.00
Current ratio0.80×

Equity was negative — liabilities exceeded assets. No ratio is shown.

The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20232022202120202019201820172016201520142013
Revenue $B0.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.00.00.00.00.00.00.00.00.0
EBITDA $B−0.0−0.00.00.00.00.00.00.00.00.00.0
Income tax $B0.0·0.00.00.00.00.00.00.00.00.0
Net income $B−0.0−0.00.00.00.00.00.00.00.00.00.0
Free cash flow $B0.0−0.00.00.00.00.00.00.0−0.0−0.00.0
EPS, diluted $−0.00−0.010.170.150.050.130.320.250.130.050.29
Dividend / sh $···········
Payout %···········
ROE %·−5.215.522.66.114.747.667.363.049.684.4
Shares out B0.080.080.020.020.020.010.010.010.010.010.01

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 46 reconciliationsAUDITED

Reconciled in 11 of 19 fiscal years. 44 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Hospitals
Listed onnot stated in the filings
Incorporated inFlorida
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2013

Share this section

Download image